Search Results

BARDA provides funding to Vaxart, U. of Cambridge for flu vaccine improvements

vaccine candidate, which in previous studies has shown the potential to elicit an immune response ...

China gets its due with Nobel, but research problems still remain

transmission of malaria parasite in mice Final trial results show GSK malaria vaccine's efficacy wanes ...

Smart foot and ankle brace launches; ConforMIS ends recall investigation;

cancer vaccine on hold. Article Pharma News @FiercePharma: Something's got to give in India's ...

Study says using hep C drugs early will save healthcare dollars; Pfizer's Chantix found to initially help women more than men stop smoking;

Report > Advaxis offers a tardy defense after FDA puts cancer vaccine on hold. Article Biotech ...

Cell Therapy mulls IPO as regenerative medicine boards EMA fast track

year. While keeping tabs on financing options, Cell Therapy will work on its regulatory filing ahead ...

Merck-partnered Euroscreen raises €16M to support IND filing

the filing of an IND with FDA and a final tranche for long-term toxicology tests. The toxicology tests ...

DBV shares tick up on long-term data from PhIII-ready peanut allergy drug

Related Articles: DBV files to raise $245M to fuel race for peanut allergy market DBV makes a beeline ...

Merck KGaA and Pfizer get their fifth-place immunotherapy on the FDA fast track

and lung cancer in the U.S. On their tails is Roche ($RHHBY), which is soon to file its PD-L1-targeting ...

Valeant hits back at price-hike critics amid national scrutiny

Valeant's filing- get more from Bloomberg Special Reports: 10 big brands keep pumping out big bucks, ...

OptiNose raises up to $30M to get drug-device combo through FDA

filings; its investors include Avista Capital Partners, WFD Ventures and Entrepreneurs Fund.- here ...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • next ›
  • last »